Go to main page
 
Consolidated financial statements
+§ Audited by PwC

Balance sheet - the Novozymes Group

Note Dec. 31, 2006   Dec. 31, 2005
      DKK million DKK million  
ASSETS
10 Intangible fixed assets 769  431 
11 Property, plant and equipment 3,553  3,477 
12 Deferred tax assets 45  42 
Financial assets   12  20   
Total fixed assets 4,379  3,970 
13 Inventories 1,326  1,197 
14 Trade receivables 1,193  1,056 
15 Tax receivable 248  318 
16 Other receivables 145  163 
17 Financial assets 177  151 
Cash at bank and in hand   497  454   
Total current assets 3,586  3,339 
Total assets   7,965  7,309   
           
LIABILITIES AND SHAREHOLDERS' EQUITY
18 Share capital 650  696 
18 Treasury shares (1,449) (1,659)
Other reserves 86  122 
Retained earnings 4,072  4,602 
19 Minority interests   34  33   
Total shareholders' equity 3,393  3,794 
12 Deferred tax liabilities 756  574 
20 Long-term employee benefits 15  17 
21 Provisions 134  63 
22 Financial liabilities 1,708  1,396 
Other non-current liabilities   21  23   
Non-current liabilities 2,634  2,073 
23 Financial liabilities 461  168 
21 Provisions 20  11 
Trade payables 386  313 
15 Tax payable 50  48 
24 Other current liabilities   1,021  902   
Total current liabilities 1,938  1,442 
         
Total liabilities 4,572  3,515 
Total liabilities and shareholders' equity 7,965  7,309